Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 2/20 | 0.36 |
| ▸ | PRCP | P42785 | 1/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.35 |
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
| ▸ | FAP | Q12884 | 1/20 | 0.33 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 2/20 | 0.32 |
| ▸ | CTSC | P53634 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24587253 | 0.83 | TLR2 (0.40) | TLR2PRCPDPP7DPP4FAP | |
| SCHEMBL27114716 | 0.83 | TLR2 (0.40) | TLR2PRCPDPP7DPP4FAP | |
| SCHEMBL8840314 | 0.80 | PRCP (0.39) | TLR2PRCPDPP7DPP4FAP | |
| SCHEMBL3714016 | 0.78 | RAB9A (0.39) | TLR2PRCPDPP7DPP4FAP | |
| SCHEMBL10363588 | 0.78 | RAB9A (0.39) | TLR2PRCPDPP7DPP4FAP | |
| SCHEMBL24586238 | 0.76 | DPP4 (0.36) | TLR2PRCPDPP7DPP4FAP | |
| SCHEMBL17732291 | 0.76 | PRCP (0.38) | TLR2PRCPDPP7DPP4FAP | |
| SCHEMBL25397085 | 0.75 | ADRB2 (0.36) | TLR2PRCPDPP7DPP4FAP | |
| SCHEMBL1263537 | 0.75 | TLR2 (0.35) | TLR2PRCPDPP7DPP4FAP | |
| SCHEMBL10030565 | 0.75 | NOS2 (0.42) | TLR2PRCPDPP7DPP4FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240065261-A1 | PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME | UNIV NEW YORK STATE RES FOUND (US) | 2024-02-29 | — | — | US | disclosed |
| WO-2022140458-A1 | PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2022-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240065261-A1 | PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME | SLC29A1, SLC29A2, SLC43A1 | TLR2 2977/4885PRCP 1285/4885DPP7 3977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.